Literature DB >> 36051951

EASL clinical practice guidelines: non-invasive liver tests for evaluation of liver disease severity and prognosis.

Ann J Archer1,2, Katherine J Belfield1,3, James G Orr1, Fiona H Gordon1, Kushala Wm Abeysekera1,2.   

Abstract

The European Association for the Study of the Liver has recently published updated guidelines on the use of non-invasive tests to identify and stratify chronic liver disease. Here, we provide a summary of the key recommendations from the guideline. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  alcoholic liver disease; hepatic fibrosis; liver function test; non-alcoholic steatohepatitis; screening

Year:  2022        PMID： 36051951      PMCID： PMC9380759          DOI： 10.1136/flgastro-2021-102064

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN： 2041-4137


  10 in total

1.  Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease.

Authors:  Ankur Srivastava; Ruth Gailer; Sudeep Tanwar; Paul Trembling; Julie Parkes; Alison Rodger; Deepak Suri; Douglas Thorburn; Karen Sennett; Sarah Morgan; Emmanuel A Tsochatzis; William Rosenberg
Journal:  J Hepatol       Date:  2019-04-06       Impact factor: 25.083

2.  EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis.

Authors: 
Journal:  J Hepatol       Date:  2015-04-21       Impact factor: 25.083

3.  Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.

Authors:  Roberto de Franchis
Journal:  J Hepatol       Date:  2015-06-03       Impact factor: 25.083

Review 4.  Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis.

Authors:  Siddharth Singh; Antonio Facciorusso; Rohit Loomba; Yngve T Falck-Ytter
Journal:  Clin Gastroenterol Hepatol       Date:  2017-05-04       Impact factor: 11.382

Review 5.  Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.

Authors:  Parambir S Dulai; Siddharth Singh; Janki Patel; Meera Soni; Larry J Prokop; Zobair Younossi; Giada Sebastiani; Mattias Ekstedt; Hannes Hagstrom; Patrik Nasr; Per Stal; Vincent Wai-Sun Wong; Stergios Kechagias; Rolf Hultcrantz; Rohit Loomba
Journal:  Hepatology       Date:  2017-03-31       Impact factor: 17.425

6.  Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis.

Authors:  David Petroff; Valentin Blank; Philip N Newsome; Cosmin Sebastian Voican; Maja Thiele; Victor de Lédinghen; Stephan Baumeler; Wah Kheong Chan; Gabriel Perlemuter; Ana-Carolina Cardoso; Sandeep Aggarwal; Magali Sasso; Peter J Eddowes; Michael Allison; Emmanuel Tsochatzis; Quentin M Anstee; David Sheridan; Jeremy F Cobbold; Sylvie Naveau; Monica Lupsor-Platon; Sebastian Mueller; Aleksander Krag; Marie Irles-Depe; David Semela; Grace Lai-Hung Wong; Vincent Wai-Sun Wong; Cristiane A Villela-Nogueira; Harshit Garg; Olivier Chazouillères; Johannes Wiegand; Thomas Karlas
Journal:  Lancet Gastroenterol Hepatol       Date:  2021-01-15

7.  Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.

Authors:  Arun J Sanyal; Mark L Van Natta; Jeanne Clark; Brent A Neuschwander-Tetri; AnnaMae Diehl; Srinivasan Dasarathy; Rohit Loomba; Naga Chalasani; Kris Kowdley; Bilal Hameed; Laura A Wilson; Katherine P Yates; Patricia Belt; Mariana Lazo; David E Kleiner; Cynthia Behling; James Tonascia
Journal:  N Engl J Med       Date:  2021-10-21       Impact factor: 176.079

8.  EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update.

Authors: 
Journal:  J Hepatol       Date:  2021-06-21       Impact factor: 25.083

Review 9.  New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UK.

Authors:  Roger Williams; Charles Alessi; Graeme Alexander; Michael Allison; Richard Aspinall; Rachel L Batterham; Neeraj Bhala; Natalie Day; Anil Dhawan; Colin Drummond; James Ferguson; Graham Foster; Ian Gilmore; Raphael Goldacre; Harriet Gordon; Clive Henn; Deirdre Kelly; Alastair MacGilchrist; Roger McCorry; Neil McDougall; Zulfiquar Mirza; Kieran Moriarty; Philip Newsome; Richard Pinder; Stephen Roberts; Harry Rutter; Stephen Ryder; Marianne Samyn; Katherine Severi; Nick Sheron; Douglas Thorburn; Julia Verne; John Williams; Andrew Yeoman
Journal:  Lancet       Date:  2021-03-11       Impact factor: 202.731

10.  The Development and Implementation of a Commissioned Pathway for the Identification and Stratification of Liver Disease in the Community.

Authors:  J Chalmers; E Wilkes; R Harris; L Kent; S Kinra; G P Aithal; M Holmes; J Johnson; J R Morling; I N Guha
Journal:  Frontline Gastroenterol       Date:  2019-06-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.